Dimension Vista LOCI Total Testosterone Flex reagent cartridge, Dimension Vista Testosterone Calibrator
Radioimmunoassay, Testosterones And Dihydrotestosterone. 510(k) K151529, from Siemens Healthcare Diagnostics, Inc. (Newark, DE). Product code CDZ, class 1.
As of Nov 20, 2026, K151529 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Feb 11, 2016 after 248 days, with 1 recall tied to it in FDA's recall database.
- Review time: 248 days
- Recalls: 1
The Dimension Vista® LOCI Total Testosterone Flex® reagent cartridge is an in vitro diagnostic test for the quantitative measurement of total testosterone in human serum and plasma on the Dimension Vista® System.
- Elecsys Testosterone Ii ImmunoassayK093421 · Roche Diagnostics Corp. · Apr 23, 2010
- Elecsys Testosterone Calset IiK003411 · Roche Diagnostics Corp. · Mar 1, 2001
| Started | Recall | Status |
|---|---|---|
| Mar 21, 2018 | Z-2438-2018The diluent may have an incomplete slit on the septum in the cap of the vial. A diluent cap with a defective septum has the potential to cause erroneously elevated results if a sample is autodiluted onboard the system,… | Terminated |
- IDS-iSYS Total TestosteroneK252728 · Immunodiagnostic Systems Limited · Apr 15, 2026
- IDS-iSYS Free TestosteroneK240865 · Immunodiagnostic Systems Limited · Oct 23, 2024
- Access SHBGK233480 · Beckman Coulter, Inc. · Feb 8, 2024
- Access TestosteroneK223405 · Beckman Coulter, Inc. · Jan 13, 2023
- Elecsys Testosterone IIK211685 · Roche Diagnostics · May 6, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 8, 2015
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files